alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,001–5,025 of 7,816 matching trials · page 201 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Symptomatic Therapy for Patients With Huntington's Disease
NCT04071639
Haloperidol 2Mg Tab; Risperidone 1Mg Tab; Zoloft 50Mg Tablet; Idebe...
Runs in: China · 1 site 		PHASE1
other		 UNKNOWN 60 Second Affiliated Hospital, Zhejiang University, School of Medicine
OTHER		 2021-04-02
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
NCT03044249
MP-101; Placebo
Runs in: Canada; United States · 20 sites 		PHASE2
other		 TERMINATED 81 Mediti Pharma Inc.
OTHER		 2021-04-01
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
NCT03785067
telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg; Placebo ora...
Runs in: Australia; Netherlands · 4 sites 		PHASE3
other		 TERMINATED 1 The George Institute
OTHER		 2021-04-01
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
NCT04277767
observational
Runs in: China · 1 site 		NA
other		 UNKNOWN 60 Zhongshan Ophthalmic Center, Sun Yat-sen University
OTHER		 2021-04-01
DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes
NCT03877783
mediterranean diet; individualized fitness program; recommended mod...
Runs in: Sweden · 1 site 		NA
other		 UNKNOWN 10 Umeå University
OTHER		 2021-03-26
Nintendo Wii Virtual Reality Application In Dementia
NCT04819126
Nintendo Wii Virtual Reality Application
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 COMPLETED 32 Kırıkkale University
OTHER		 2021-03-26
Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
NCT00955409
ACC-001(3µg) + QS21; ACC-001(10µg) + QS21; ACC-001(30µg) + QS21
Runs in: France; Germany; Spain · 17 sites 		PHASE2
other		 COMPLETED 160 Pfizer
INDUSTRY		 2021-03-25
Patients With Alzheimer's Disease or Related Youth Disease
NCT03508024
Runs in: France · 1 site 		NA
other		 COMPLETED 220 University Hospital, Lille
OTHER		 2021-03-25
Mnemonic Strategy Versus Spaced Retrieval Training in Those With Mild Cognitive Impairment
NCT04533204
mnemonic strategy training; spaced retrieval training
Runs in: United States · 1 site 		NA
other		 COMPLETED 59 VA Office of Research and Development
OTHER_GOV		 2021-03-23
Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation.
NCT02814045
Runs in: Spain · 2 sites 		NA
other		 COMPLETED 144 Sociedad Española de Neumología y Cirugía Torácica
OTHER		 2021-03-22
Can Magnetic Brain Stimulation Improve Language Function in Primary Progressive Aphasia
NCT04193267
MagStim Rapid2 Transcranial Magnetic Simulation
Runs in: Canada · 1 site 		NA
other		 UNKNOWN 10 University of Manitoba
OTHER		 2021-03-22
Brain Network Activation in Patients With Movement Disorders
NCT03269201
Runs in: Israel · 1 site 		NA
other		 UNKNOWN 300 Sheba Medical Center
OTHER_GOV		 2021-03-19
Gamma tACS in Alzheimer's Disease
NCT04515433
Gamma tACS (40 Hz) over the superior parietal cortex
Runs in: Italy · 1 site 		NA
other		 COMPLETED 20 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
OTHER		 2021-03-19
Development and Decline of Brain and Cognition Through the Life Span
NCT00880451
Runs in: United States · 1 site 		NA
other		 COMPLETED 0 National Institute of Mental Health (NIMH)
NIH		 2021-03-16
Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
NCT03839355
Apixaban; Warfarin
Runs in: United States · 1 site 		PHASE3
other		 TERMINATED 34 Mayo Clinic
OTHER		 2021-03-16
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
NCT03969732
1. amyloid PET；2. T807 PET
Runs in: Taiwan · 1 site 		PHASE3
other		 UNKNOWN 240 National Taiwan University Hospital
OTHER		 2021-03-12
Immunoadsorption for Treatment of Alzheimer's Disease
NCT03132272
Immunoadsorption with Globaffin
Runs in: Germany · 1 site 		NA
other		 TERMINATED 11 University Medicine Greifswald
OTHER		 2021-03-09
Reducing Aggression Among People With an Intellectual Disability
NCT03212092
Multivitamin, mineral & n-3 FA; Placebo
Runs in: Netherlands · 7 sites 		NA
other		 COMPLETED 137 Leiden University Medical Center
OTHER		 2021-03-09
Ageing Gut Brain Interactions
NCT03593941
Standard Diet
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 60 University of Aberdeen
OTHER		 2021-03-09
Effects of Multicomponent Physical Exercise Program and Mediterranean Diet in Alzheimer's Disease
NCT04439097
Multicomponent physical exercise program associated with a Mediterr...
Runs in: Spain · 1 site 		NA
other		 UNKNOWN 84 University of Salamanca
OTHER		 2021-03-09
Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
NCT02055092
Runs in: Norway · 1 site 		NA
other		 COMPLETED 250 Norwegian Centre for Ageing and Health
OTHER		 2021-03-08
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
NCT01097096
CAD106; Placebo; Alum; MF59
Runs in: Belgium; Canada; Germany; Italy; Netherlands; Norway; Spa... · 31 sites 		PHASE2
other		 COMPLETED 177 Novartis Pharmaceuticals
INDUSTRY		 2021-03-05
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
NCT02322021
E2609; Placebo
Runs in: United States · 21 sites 		PHASE2
other		 TERMINATED 70 Eisai Inc.
INDUSTRY		 2021-03-05
Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
NCT02444637
Rivastigmine
Runs in: Singapore · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 100 National Neuroscience Institute
OTHER		 2021-03-05
Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease
NCT03867253
ORY-2001 Low dose; ORY-2001 High dose; Placebo
Runs in: United States · 4 sites 		PHASE2
other		 COMPLETED 24 Oryzon Genomics S.A.
INDUSTRY		 2021-03-05

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →